Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2/3 1Phase 2 1

Status

Unknown 2Active not recruiting 1

Sponsor Class

OTHER 103OTHER_GOV 3INDUSTRY 3UNKNOWN 1NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2Tumor-Agnostic 1Head & Neck 1

Conditions

Wounds and Injuries 1Operable Breast Cancer 1Neoplasms 1Head and Neck Neoplasms 1Cancer Pain 1Breast Neoplasms 1

Interventions

Cisplatin 49Capecitabine 41apatinib 34Gemcitabine 33Oxaliplatin 32Cyclophosphamide 31Radiotherapy 29Paclitaxel 29Carboplatin 29tislelizumab 27Irinotecan 27Drug Therapy 27Fluorouracil 26Docetaxel 26Bevacizumab 23fludarabine 18Surgical Procedures, Operative 17Nivolumab 17pembrolizumab 16Exercise 16Metformin 15camrelizumab 14S 1 (combination) 14Radiation 14Pemetrexed 13Control Groups 12anlotinib 11Leucovorin 11toripalimab 10Vinorelbine 10

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × Interventional × Lidocaine × Clear all
NCT01916317 2025-04-09

Randomized Controlled Trial to Assess Blockade of Voltage Gated Sodium Channels During Surgery in Operable Breast Cancer

Tata Memorial Hospital

Phase 3 Active not recruiting
1,600 enrolled
Breast

Operable Breast Cancer

NCT05800834 2023-09-28

MorphineGEL

Instituto Nacional de Cancer, Brazil

Phase 2 Unknown
106 enrolled
BreastHead & Neck

Cancer Pain, Breast Neoplasms, Head and Neck Neoplasms, Wounds and Injuries

NCT04741880 2021-07-30

ELSA

Instituto Nacional de Cancer, Brazil

Phase 2/3 Unknown
66 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡